LAS VEGAS, March 1, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announced today that the company has closed its acquisition of Metastatin Pharmaceuticals, Inc., a biopharmaceutical company focused on molecularly targeted Cancer drugs to control tumor progression and metastasis.
